_id
690f3d8accc777a4e85d1ab4
Ticker
CEROW
Name
CERo Therapeutics Holdings Inc
Exchange
NASDAQ
Address
201 Haskins Way, South San Francisco, CA, United States, 94080
Country
USA
Sector
Industry
Currency
USD
Website
https://www.cero.bio
Description
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Last Close
0.0056
Volume
50000
Current Price
0.0055
Change
-0.0034
Last Updated
2026-01-02T11:10:49.739Z
Image
data:image/webp;base64,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
Ipo Date
2021-11-29T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
4362579
Operating Income
-4362579
Interest Expense
5936
Pretax Income
-11506223
Net Income
-11506223
Eps
-9.096662618864654
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-4362579
Operating Margin
-
Total Other Income Expense Net
-7143644
Cash
2022072
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
2553899
Property Plant Equipment
1182990
Total Assets
3911394
Payables
7077342
Short Term Debt
931023
Long Term Debt
-
Total Liabilities
8454556
Equity
-4543162
Bs_currency_symbol
USD
Depreciation
272766
Change In Working Capital
434412
Cash From Operations
-3205115
Capital Expenditures
0
Cash From Investing
500000
Cash From Financing
1424513
Net Change In Cash
-1280602
Cf_currency_symbol
USD
PE
-
PB
-0.0015312819573680182
ROE
253.26464255511908
ROA
-294.17192438296934
FCF
-3205115
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
0
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
4362579
Quarters > 0 > income Statement > operating Income
-4362579
Quarters > 0 > income Statement > interest Expense
5936
Quarters > 0 > income Statement > pretax Income
-11506223
Quarters > 0 > income Statement > net Income
-11506223
Quarters > 0 > income Statement > eps
-9.096662618864654
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1264884
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4362579
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-7143644
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2022072
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2553899
Quarters > 0 > balance Sheet > property Plant Equipment
1182990
Quarters > 0 > balance Sheet > total Assets
3911394
Quarters > 0 > balance Sheet > payables
7077342
Quarters > 0 > balance Sheet > short Term Debt
931023
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
8454556
Quarters > 0 > balance Sheet > equity
-4543162
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-4856395
Quarters > 0 > cash Flow > depreciation
272766
Quarters > 0 > cash Flow > change In Working Capital
434412
Quarters > 0 > cash Flow > cash From Operations
-3205115
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
500000
Quarters > 0 > cash Flow > cash From Financing
1424513
Quarters > 0 > cash Flow > net Change In Cash
-1280602
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-9.096662618864654
Quarters > 0 > ratios > PB
-0.0015312819573680182
Quarters > 0 > ratios > ROE
253.26464255511908
Quarters > 0 > ratios > ROA
-294.17192438296934
Quarters > 0 > ratios > FCF
-3205115
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
267657
Quarters > 1 > income Statement > gross Profit
-267657
Quarters > 1 > income Statement > operating Expenses
4723791
Quarters > 1 > income Statement > operating Income
-4723791
Quarters > 1 > income Statement > interest Expense
13776
Quarters > 1 > income Statement > pretax Income
-5417315
Quarters > 1 > income Statement > net Income
-5417315
Quarters > 1 > income Statement > eps
-11.099326744195576
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
488076
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-5163434
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-693524
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
3302674
Quarters > 1 > balance Sheet > short Term Investments
500000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
4246566
Quarters > 1 > balance Sheet > property Plant Equipment
1455756
Quarters > 1 > balance Sheet > total Assets
6202322
Quarters > 1 > balance Sheet > payables
6213045
Quarters > 1 > balance Sheet > short Term Debt
1868620
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7836223
Quarters > 1 > balance Sheet > equity
-1633901
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5417315
Quarters > 1 > cash Flow > depreciation
267657
Quarters > 1 > cash Flow > change In Working Capital
-364005
Quarters > 1 > cash Flow > cash From Operations
-4623035
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2722172
Quarters > 1 > cash Flow > net Change In Cash
-1900863
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-11.099326744195576
Quarters > 1 > ratios > PB
-0.001642950215465931
Quarters > 1 > ratios > ROE
331.5571139255071
Quarters > 1 > ratios > ROA
-87.34333689866473
Quarters > 1 > ratios > FCF
-4623035
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1162826
Quarters > 2 > income Statement > cost Of Revenue
269475
Quarters > 2 > income Statement > gross Profit
-269475
Quarters > 2 > income Statement > operating Expenses
4950531
Quarters > 2 > income Statement > operating Income
-4950531
Quarters > 2 > income Statement > interest Expense
26606
Quarters > 2 > income Statement > pretax Income
-5105931
Quarters > 2 > income Statement > net Income
-5105931
Quarters > 2 > income Statement > eps
-29.79303886101062
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
171380
Quarters > 2 > income Statement > income Tax Expense
1
Quarters > 2 > income Statement > EBITDA
-4837000
Quarters > 2 > income Statement > operating Margin
-425.7327407539907
Quarters > 2 > income Statement > total Other Income Expense Net
-155400
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
5203537
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5768000
Quarters > 2 > balance Sheet > property Plant Equipment
1723413
Quarters > 2 > balance Sheet > total Assets
7991414
Quarters > 2 > balance Sheet > payables
6379056
Quarters > 2 > balance Sheet > short Term Debt
1810010
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8320800
Quarters > 2 > balance Sheet > equity
-329386
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5105931
Quarters > 2 > cash Flow > depreciation
269475
Quarters > 2 > cash Flow > change In Working Capital
-70407
Quarters > 2 > cash Flow > cash From Operations
-4445667
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-4
Quarters > 2 > cash Flow > cash From Financing
6322144
Quarters > 2 > cash Flow > net Change In Cash
1876477
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-29.79303886101062
Quarters > 2 > ratios > PB
-0.0028616577510883886
Quarters > 2 > ratios > ROE
1550.136010637975
Quarters > 2 > ratios > ROA
-63.89271035138462
Quarters > 2 > ratios > FCF
-4445671
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-3.823160988832379
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
297340
Quarters > 3 > income Statement > gross Profit
-297340
Quarters > 3 > income Statement > operating Expenses
4402238
Quarters > 3 > income Statement > operating Income
-4402238
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-4227967
Quarters > 3 > income Statement > net Income
-4227967
Quarters > 3 > income Statement > eps
-170.22857027821397
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
24837
Quarters > 3 > income Statement > income Tax Expense
-4227967
Quarters > 3 > income Statement > EBITDA
-4402238
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
174271
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3380204
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3714483
Quarters > 3 > balance Sheet > property Plant Equipment
2277514
Quarters > 3 > balance Sheet > total Assets
6491997
Quarters > 3 > balance Sheet > payables
6667073
Quarters > 3 > balance Sheet > short Term Debt
1033297
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
10194422
Quarters > 3 > balance Sheet > equity
-3702425
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-4227
Quarters > 3 > cash Flow > depreciation
297.34
Quarters > 3 > cash Flow > change In Working Capital
-627764
Quarters > 3 > cash Flow > cash From Operations
-2758211
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-185236
Quarters > 3 > cash Flow > cash From Financing
2491766
Quarters > 3 > cash Flow > net Change In Cash
-266822
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-170.22857027821397
Quarters > 3 > ratios > PB
-0.00003689568323463676
Quarters > 3 > ratios > ROE
114.19453466309244
Quarters > 3 > ratios > ROA
-65.12583108094474
Quarters > 3 > ratios > FCF
-2758211
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
1163379
Annuals > 0 > income Statement > gross Profit
-1163379
Annuals > 0 > income Statement > operating Expenses
15300903
Annuals > 0 > income Statement > operating Income
-15300903
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-7732212
Annuals > 0 > income Statement > net Income
-7732000
Annuals > 0 > income Statement > eps
-64.00980181134824
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
120794
Annuals > 0 > income Statement > income Tax Expense
-11089262
Annuals > 0 > income Statement > EBITDA
-6569309
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
7568691
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
3327060
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3714041
Annuals > 0 > balance Sheet > property Plant Equipment
1992888
Annuals > 0 > balance Sheet > total Assets
6206929
Annuals > 0 > balance Sheet > payables
4507318
Annuals > 0 > balance Sheet > short Term Debt
876392
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8101492
Annuals > 0 > balance Sheet > equity
-1894563
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-8304423
Annuals > 0 > cash Flow > depreciation
1117198
Annuals > 0 > cash Flow > change In Working Capital
1837191
Annuals > 0 > cash Flow > cash From Operations
-5789987
Annuals > 0 > cash Flow > capital Expenditures
1
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
571678
Annuals > 0 > cash Flow > net Change In Cash
-5218309
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-64.00980181134824
Annuals > 0 > ratios > PB
-0.00035704613676082556
Annuals > 0 > ratios > ROE
408.1152223494283
Annuals > 0 > ratios > ROA
-124.57045988442917
Annuals > 0 > ratios > FCF
-5789988
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
38
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1117198
Annuals > 1 > income Statement > gross Profit
-1117198
Annuals > 1 > income Statement > operating Expenses
2932985
Annuals > 1 > income Statement > operating Income
-2932985
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-2441414
Annuals > 1 > income Statement > net Income
-2536
Annuals > 1 > income Statement > eps
-0.3448932408540732
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
7353
Annuals > 1 > income Statement > income Tax Expense
94819
Annuals > 1 > income Statement > EBITDA
-2438482
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
491571
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1601255
Annuals > 1 > balance Sheet > short Term Investments
8436311
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1970035
Annuals > 1 > balance Sheet > property Plant Equipment
3156267
Annuals > 1 > balance Sheet > total Assets
5126302
Annuals > 1 > balance Sheet > payables
3535084
Annuals > 1 > balance Sheet > short Term Debt
1555000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
47183997
Annuals > 1 > balance Sheet > equity
-5762811
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-7289577
Annuals > 1 > cash Flow > depreciation
1117198
Annuals > 1 > cash Flow > change In Working Capital
540105
Annuals > 1 > cash Flow > cash From Operations
-5789987
Annuals > 1 > cash Flow > capital Expenditures
3
Annuals > 1 > cash Flow > cash From Investing
-7944
Annuals > 1 > cash Flow > cash From Financing
571678
Annuals > 1 > cash Flow > net Change In Cash
-5218309
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.3448932408540732
Annuals > 1 > ratios > PB
-0.000007145262962814501
Annuals > 1 > ratios > ROE
0.0440063017857084
Annuals > 1 > ratios > ROA
-0.04947035894490805
Annuals > 1 > ratios > FCF
-5789990
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
2905441
Annuals > 2 > income Statement > operating Income
-2905440
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-68577
Annuals > 2 > income Statement > net Income
-667736
Annuals > 2 > income Statement > eps
-90.81136950904393
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
7353
Annuals > 2 > income Statement > income Tax Expense
599159
Annuals > 2 > income Statement > EBITDA
-68577
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2836864
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
42141844
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
42367032
Annuals > 2 > balance Sheet > property Plant Equipment
4273465
Annuals > 2 > balance Sheet > total Assets
42367032
Annuals > 2 > balance Sheet > payables
1653120
Annuals > 2 > balance Sheet > short Term Debt
650000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
39898341
Annuals > 2 > balance Sheet > equity
2468691
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-11829116
Annuals > 2 > cash Flow > depreciation
1072809
Annuals > 2 > cash Flow > change In Working Capital
2412353
Annuals > 2 > cash Flow > cash From Operations
-1092247
Annuals > 2 > cash Flow > capital Expenditures
694232
Annuals > 2 > cash Flow > cash From Investing
180839396
Annuals > 2 > cash Flow > cash From Financing
-138703878
Annuals > 2 > cash Flow > net Change In Cash
41043271
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-90.81136950904393
Annuals > 2 > ratios > PB
0.000016679608748117928
Annuals > 2 > ratios > ROE
-27.048180594493193
Annuals > 2 > ratios > ROA
-1.576074528893126
Annuals > 2 > ratios > FCF
-1786479
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
15
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
431496
Annuals > 3 > income Statement > operating Income
-332030
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-332415
Annuals > 3 > income Statement > net Income
-315547
Annuals > 3 > income Statement > eps
-42.914048687610496
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
7353
Annuals > 3 > income Statement > income Tax Expense
-16868
Annuals > 3 > income Statement > EBITDA
403058
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-385
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1098573
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1361073
Annuals > 3 > balance Sheet > property Plant Equipment
4652043
Annuals > 3 > balance Sheet > total Assets
180078207
Annuals > 3 > balance Sheet > payables
14433
Annuals > 3 > balance Sheet > short Term Debt
585250
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
9248072
Annuals > 3 > balance Sheet > equity
170830135
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-10629620
Annuals > 3 > cash Flow > depreciation
735473
Annuals > 3 > cash Flow > change In Working Capital
-365079
Annuals > 3 > cash Flow > cash From Operations
-697109
Annuals > 3 > cash Flow > capital Expenditures
612566
Annuals > 3 > cash Flow > cash From Investing
-178500000
Annuals > 3 > cash Flow > cash From Financing
180295682
Annuals > 3 > cash Flow > net Change In Cash
1098573
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-42.914048687610496
Annuals > 3 > ratios > PB
2.410394395578977e-7
Annuals > 3 > ratios > ROE
-0.18471389722896372
Annuals > 3 > ratios > ROA
-0.17522775534965204
Annuals > 3 > ratios > FCF
-1309675
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-9.096662618864654
Valuation > metrics > PB
-0.0015312819573680182
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
253.26464255511908
Profitability > metrics > ROA
-450.5355536769465
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-734.9358153638814
Risk > final Score
-2910
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.31890392108751286
Liquidity > metrics > Quick Ratio
0.31890392108751286
Liquidity > final Score
26
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
40
Prev Profitabilities > 2
55
Prev Risks > 0
-1342
Prev Risks > 1
-714
Prev Risks > 2
-71
Prev Liquidities > 0
36
Prev Liquidities > 1
45
Prev Liquidities > 2
34
Updated At
2026-01-20T21:34:53.684Z
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASwing Trade: Will New York Mortgage Trust Inc stock hit new highs in YEAR baoquankhu1.vn
Read more →Is Brookfield Property Partners L.P. stock cheap at current valuation - Earnings Miss & AI Optimized Trading Strategy Guides bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of CERo Therapeutics Holdings Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.